Form 4: Guardant Health's Chief Medical Officer, Craig Eagle, Reports Stock Transactions
SEC Form 4 Filing
Chief Medical Officer of Guardant Health, Craig Eagle, reports the vesting of restricted stock units and associated tax withholding.
Summary
- On September 15, 2024, Craig Eagle, the Chief Medical Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- These transactions included the vesting of 1,402 restricted stock units and the subsequent withholding of 711 shares to cover tax obligations.
- Following these transactions, Eagle directly owns 19,187 shares of Guardant Health common stock and 9,813 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, and it doesn't inherently convey positive or negative sentiment. It's a neutral reporting of facts.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| June 9, 2023 | Date of restricted stock unit award grant. |
| June 15, 2024 | First vesting date of the restricted stock units (33%). |
| September 15, 2024 | Date of stock transactions: vesting of restricted stock units and tax withholding. |
| September 16, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.